NurExone Biologic Inc has been accepted into the BioFab Startup [...]
RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]
Oral BioLife, a regenerative technology company developing non-invasive therapies to [...]
DEBRA Research, a non-profit focused on Epidermolysis bullosa (EB), has [...]
1,200 m² Aachen facility will enable largest global HPL output [...]
TISSIUM has received De Novo authorization from the US Food [...]
Novadip Biosciences and Cliniques universitaires Saint-Luc have reported successful long-term [...]
Nanoscope Therapeutics begins FDA submission for gene-agnostic therapy to treat retinitis pigmentosa
Nanoscope Therapeutics has initiated a rolling submission for its Biologics [...]
Celularity and Fountain Life have formed a strategic partnership to [...]
FDA recognises regenerative approach for congenital pseudarthrosis of the tibia [...]